Abstract
Aims
Inflammation is a cardinal pathogenetic mechanism in diabetic kidney injury (DKI). The detection of microalbuminuria (MA) is very important in preventing end-stage renal failure in diabetic subjects. A combination of high monocyte and low lymphocyte counts are used as a marker of inflammation. Monocyte to lymphocyte ratio (MLR) is considered as a marker in inflammatory diseases. We aimed to evaluate the MLR levels in diabetic subjects as a predictive marker in detecting MA.
Methods
A total of 212 patients with type 2 diabetes mellitus (T2DM) were included in the study. Patients with T2DM were divided into two groups as MA and normoalbuminuria (NA). MLR of the groups were compared.
Results
There were 72 patients in MA and 140 patients in NA group. MLR of the MA and NA groups were 0.247 (0.131–0.540) and 0.211 (0.052–0.390), respectively (p < 0.001). There was a statistically significant correlation between MLR and MA (r = 0.228, p = 0.001). In multivariate backward logistic regression analysis, MLR, fasting blood glucose, HbA1c and presence of comorbid clinical diseases were determined as independent predictors of DKI.
Conclusions
We suggest that MLR could serve as a predictive and effective marker for DKI in diabetic subjects due to its strong correlation with MA and inexpensive and readily available nature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediat Inflamm. 2012;2012.
Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–43.
Nunez J, Minana G, Bodi V, Nunez E, Sanchis J, Husser O, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226–33.
Greene SJ, Harinstein ME, Vaduganathan M, Subačius H, Konstam MA, Zannad F, et al. Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol. 2012;110(11):1657–62.
Gong S, Gao X, Xu F, Shang Z, Li S, Chen W, et al. Association of lymphocyte to monocyte ratio with severity of coronary artery disease. Medicine. 2018;97(43).
Gary T, Pichler M, Belaj K, Eller P, Hafner F, Gerger A, et al. Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract. 2014;68(12):1483–7. https://doi.org/10.1111/ijcp.12495.
Wang J, Gao K, Lei W, Dong L, Xuan Q, Feng M, et al. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes. Oncotarget. 2017;8(3):5414–25. https://doi.org/10.18632/oncotarget.14289.
Haller H, Ji L, Stahl K, Bertram A, Menne J. Molecular mechanisms and treatment strategies in diabetic nephropathy: new avenues for calcium dobesilate-free radical scavenger and growth factor inhibition. BioMed Res Int. 2017;2017:1909258. https://doi.org/10.1155/2017/1909258.
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl 2):64–78. https://doi.org/10.2337/diab.32.2.s64.
Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7(6):327–40. https://doi.org/10.1038/nrneph.2011.51.
Cao L, Boston A, Jegede O, Newman HA, Harrison SH, Newman RH, et al. Inflammation and kidney injury in diabetic African American men. J Diabetes Res. 2019. https://doi.org/10.1155/2019/5359635.
Choudhary N, Ahlawat RS. Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria. Iran J Kidney Dis. 2008;2(2):72–9.
Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clin Biochem. 2018;52:131–6.
Zou ZY, Liu HL, Ning N, Li SY, Du XH, Li R. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett. 2016;11(3):2241–8. https://doi.org/10.3892/ol.2016.4216.
Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, et al. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015;113(1):150–8. https://doi.org/10.1038/bjc.2015.183.
Li Y, Li H, Li W, Wang L, Yan Z, Yao Y, et al. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma. J Clin Lab Anal. 2017;31(5). https://doi.org/10.1002/jcla.22107.
Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345–57. https://doi.org/10.3343/alm.2019.39.4.345.
Fidan K, Kocak MZ. Assessment of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ulcerative colitis: a retrospective study. EurasianJ Med Oncol. 2017;1(4):224–7.
Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2017;11:127-S31.
Huang W, Huang J, Liu Q, Lin F, He Z, Zeng Z, et al. Neutrophil–lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol. 2015;82(2):229–33.
Kocak MZ, Fidan K. Could the Neutrophil-to-Lymphocyte ratio be a marker of acute inflammation in chronic obstructive pulmonary disease? EurasianJ Med Investig. 2017;2(1):8–11.
Cherfane CE, Gessel L, Cirillo D, Zimmerman MB, Polyak S. Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity. Inflamm Bowel Dis. 2015;21(8):1769–75. https://doi.org/10.1097/mib.0000000000000427.
Huang Y, Deng W, Zheng S, Feng F, Huang Z, Huang Q, et al. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis. Int Immunopharmacol. 2018;57:43–6. https://doi.org/10.1016/j.intimp.2018.02.008.
Cananzi FCM, Minerva EM, Sama L, Ruspi L, Sicoli F, Conti L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119(1):12–20. https://doi.org/10.1002/jso.25290.
Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009–19.
Caramori ML, Mauer M. Diabetes and nephropathy. Curr Opin Nephrol Hypertens. 2003;12(3):273–82.
Funding
This work has not received any funds or grants from any organizations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no conflict of interest.
Ethics approval and consent to participate
The study protocol was approved by the local Ethics Committee of the Institution (Ethical Decision Date/Number: 2018/261).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kocak, M.Z., Aktas, G., Duman, T.T. et al. Monocyte lymphocyte ratio As a predictor of Diabetic Kidney Injury in type 2 Diabetes mellitus; The MADKID Study. J Diabetes Metab Disord 19, 997–1002 (2020). https://doi.org/10.1007/s40200-020-00595-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-020-00595-0